Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) Total Tax Payable: ¥8.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688488 Jiangsu Aidea Pharmaceutical Group Co Ltd SHSE:688488
65 GF Score
Price ¥15.78
GF Value ¥25.88
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Jiangsu Aidea Pharmaceutical Group Co Total Tax Payable?

Jiangsu Aidea Pharmaceutical Group Co SHSE:688488 -0.94% 65 Total Tax Payable is ¥8.4 Mil as of Mar. 2026. GuruFocus rates SHSE:688488 with a GF Score™ of 65/100 and a GF Value™ of ¥25.88 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Jiangsu Aidea Pharmaceutical Group Co's Total Tax Payable for the quarter that ended in Mar. 2026 was ¥8.4 Mil.

Jiangsu Aidea Pharmaceutical Group Co's quarterly Total Tax Payable increased from Sep. 2025 (¥14.0 Mil) to Dec. 2025 (¥19.8 Mil) but then declined from Dec. 2025 (¥19.8 Mil) to Mar. 2026 (¥8.4 Mil).

Jiangsu Aidea Pharmaceutical Group Co's annual Total Tax Payable increased from Dec. 2023 (¥2.1 Mil) to Dec. 2024 (¥7.9 Mil) and increased from Dec. 2024 (¥7.9 Mil) to Dec. 2025 (¥19.8 Mil).


Jiangsu Aidea Pharmaceutical Group Co Total Tax Payable Related Terms


Jiangsu Aidea Pharmaceutical Group Co Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Jiangsu Aidea Pharmaceutical Group Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Aidea Pharmaceutical Group Co Total Tax Payable Chart

Jiangsu Aidea Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.10 2.41 2.07 7.93 19.79

Jiangsu Aidea Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.21 9.77 14.04 19.79 8.45
SHSE:688488
65GF Score
Jiangsu Aidea Pharmaceutical Group Co Ltd SHSE:688488
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Aidea Pharmaceutical Group Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of ¥8.4 Mil mean?
Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) has a Total Tax Payable of ¥8.4 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Jiangsu Aidea Pharmaceutical Group Co and its competitors.
Is Jiangsu Aidea Pharmaceutical Group Co's Total Tax Payable too high?
Jiangsu Aidea Pharmaceutical Group Co's current Total Tax Payable is ¥8.4 Mil. Overall, Jiangsu Aidea Pharmaceutical Group Co has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Aidea Pharmaceutical Group Co's Total Tax Payable compare to VRTX and REGN?
Jiangsu Aidea Pharmaceutical Group Co's Total Tax Payable of ¥8.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Biotechnology company?
A good Total Tax Payable depends on the Biotechnology industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Jiangsu Aidea Pharmaceutical Group Co and its competitors. Jiangsu Aidea Pharmaceutical Group Co's current Total Tax Payable is ¥8.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Aidea Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥25.88, compared to a current price of ¥15.78 — trading 39% below its estimated fair value. The current Total Tax Payable is ¥8.4 Mil. Jiangsu Aidea Pharmaceutical Group Co's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488), the current Total Tax Payable is ¥8.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Aidea Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥15.78 is trading 39% below its estimated GF Value™ of ¥25.88. GuruFocus considers Jiangsu Aidea Pharmaceutical Group Co to be Significantly Undervalued.

Key valuation signals for SHSE:688488:

  • Total Tax Payable: ¥8.4 Mil
  • GF Value™: ¥25.88 vs. price of ¥15.78 (39% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangsu Aidea Pharmaceutical Group Co Business Description

Address No. 69, Xin Ganquan West Road, Hanjiang District, Jiangsu Province, Yangzhou, CHN, 225008
Jiangsu Aidea Pharmaceutical Group Co Ltd is engaged in the production and sales of human protein products, and also carries out some generic drug business and distributes Abbott's HIV diagnostic equipment and reagents.
65GF Score

Get the complete analysis for SHSE:688488

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.78
Price
¥25.88
GF Value